1	Neurotrophin	Neurotrophin	B-NP	NN	B-protein	3	NMOD	-1
2	p75	p75	I-NP	NN	I-protein	3	NMOD	-1
3	receptor	receptor	I-NP	NN	I-protein	7	SUB	-1
4	(	(	O	(	O	6	DEP	-1
5	p75NTR	p75NTR	B-NP	NN	B-protein	6	DEP	-1
6	)	)	O	)	O	3	NMOD	-1
7	promotes	promote	B-VP	VBZ	O	0	ROOT	17	promotes
8	endothelial	endothelial	B-NP	JJ	B-cell_type	9	NMOD	-1
9	cell	cell	I-NP	NN	I-cell_type	10	NMOD	-1
10	apoptosis	apoptosis	I-NP	NN	O	7	OBJ	5	apoptosis
11	and	and	O	CC	O	7	VMOD	-1
12	inhibits	inhibit	B-VP	VBZ	O	7	VMOD	18	inhibits
13	angiogenesis	angiogenesis	B-NP	NN	O	12	OBJ	3	angiogenesis
14	:	:	O	:	O	7	P	-1
15	implications	implication	B-NP	NNS	O	7	VMOD	-1
16	for	for	B-PP	IN	O	15	NMOD	-1
17	diabetes-induced	diabetes-induced	B-NP	JJ	O	19	NMOD	-1
18	impaired	impaired	I-NP	JJ	O	19	NMOD	18	impaired
19	neovascularization	neovascularization	I-NP	NN	O	16	PMOD	3	neovascularization
20	in	in	B-PP	IN	O	19	NMOD	-1
21	ischemic	ischemic	B-NP	JJ	O	23	NMOD	-1
22	limb	limb	I-NP	NN	O	23	NMOD	-1
23	muscles	muscle	I-NP	NNS	O	20	PMOD	-1
24	.	.	O	.	O	15	P	-1

1	Diabetes	Diabetes	B-NP	NNP	O	2	SUB	-1
2	impairs	impair	B-VP	VBZ	O	0	ROOT	18	impairs
3	endothelial	endothelial	B-NP	JJ	O	4	NMOD	-1
4	function	function	I-NP	NN	O	7	NMOD	-1
5	and	and	O	CC	O	7	NMOD	-1
6	reparative	reparative	B-NP	JJ	O	7	NMOD	-1
7	neovascularization	neovascularization	I-NP	NN	O	2	OBJ	3	neovascularization
8	.	.	O	.	O	2	P	-1

1	The	The	B-NP	DT	O	3	NMOD	-1
2	p75	p75	I-NP	NN	B-protein	3	NMOD	-1
3	receptor	receptor	I-NP	NN	I-protein	25	SUB	-1
4	of	of	B-PP	IN	O	3	NMOD	-1
5	neurotrophins	neurotrophin	B-NP	NNS	O	4	PMOD	-1
6	(	(	O	(	O	11	DEP	-1
7	p75	p75	B-NP	NN	B-protein	9	NMOD	-1
8	(	(	O	(	I-protein	9	NMOD	-1
9	NTR	NTR	B-NP	NN	I-protein	11	DEP	-1
10	)	)	O	)	I-protein	9	NMOD	-1
11	)	)	O	)	O	5	NMOD	-1
12	,	,	O	,	O	3	P	-1
13	which	which	B-NP	WDT	O	3	NMOD	-1
14	is	be	B-VP	VBZ	O	13	SBAR	-1
15	scarcely	scarcely	B-ADJP	RB	O	16	AMOD	-1
16	present	present	I-ADJP	JJ	O	14	PRD	0
17	in	in	B-PP	IN	O	16	AMOD	-1
18	healthy	healthy	B-NP	JJ	B-cell_type	20	NMOD	-1
19	endothelial	endothelial	I-NP	JJ	I-cell_type	20	NMOD	-1
20	cells	cell	I-NP	NNS	I-cell_type	17	PMOD	-1
21	(	(	O	(	O	23	DEP	-1
22	ECs	EC	B-NP	NNS	B-cell_type	23	DEP	-1
23	)	)	O	)	O	20	NMOD	-1
24	,	,	O	,	O	3	P	-1
25	becomes	become	B-VP	VBZ	O	0	ROOT	-1
26	strongly	strongly	I-VP	RB	O	25	VMOD	-1
27	expressed	express	I-VP	VBN	O	25	VC	9	expressed
28	by	by	B-PP	IN	O	27	VMOD	-1
29	capillary	capillary	B-NP	JJ	O	30	NMOD	-1
30	ECs	EC	I-NP	NNS	B-cell_type	28	PMOD	-1
31	after	after	B-PP	IN	O	27	VMOD	-1
32	induction	induction	B-NP	NN	O	31	PMOD	0
33	of	of	B-PP	IN	O	32	NMOD	-1
34	peripheral	peripheral	B-NP	JJ	O	35	NMOD	-1
35	ischemia	ischemia	I-NP	NN	O	33	PMOD	-1
36	in	in	B-PP	IN	O	32	NMOD	-1
37	type-1	type-1	B-NP	NN	O	39	NMOD	-1
38	diabetic	diabetic	I-NP	JJ	O	39	NMOD	-1
39	mice	mouse	I-NP	NNS	O	36	PMOD	-1
40	.	.	O	.	O	25	P	-1

1	Here	Here	B-ADVP	RB	O	4	VMOD	-1
2	,	,	O	,	O	4	P	-1
3	we	we	B-NP	PRP	O	4	SUB	-1
4	show	show	B-VP	VBP	O	0	ROOT	-1
5	that	that	B-SBAR	IN	O	4	VMOD	-1
6	gene	gene	B-NP	NN	O	8	NMOD	-1
7	transfer-induced	transfer-induced	I-NP	JJ	O	8	NMOD	17	induced
8	p75	p75	I-NP	NN	O	12	NMOD	-1
9	(	(	O	(	O	11	DEP	-1
10	NTR	NTR	B-NP	NN	B-protein	11	DEP	-1
11	)	)	O	)	O	8	NMOD	-1
12	expression	expression	B-NP	NN	O	13	SUB	9	expression
13	impairs	impair	B-VP	VBZ	O	5	SBAR	18	impairs
14	the	the	B-NP	DT	O	23	NMOD	-1
15	survival	survival	I-NP	NN	O	23	NMOD	5	survival
16	,	,	O	,	O	23	P	-1
17	proliferation	proliferation	B-NP	NN	O	23	NMOD	1	proliferation
18	,	,	O	,	O	23	P	-1
19	migration	migration	B-NP	NN	O	23	NMOD	14	migration
20	,	,	O	,	O	23	P	-1
21	and	and	O	CC	O	23	NMOD	-1
22	adhesion	adhesion	B-NP	NN	O	23	NMOD	15	adhesion
23	capacities	capacity	I-NP	NNS	O	13	OBJ	-1
24	of	of	B-PP	IN	O	23	NMOD	-1
25	cultured	culture	B-NP	VBN	O	26	NMOD	19	cultured
26	ECs	EC	I-NP	NNS	B-cell_type	30	NMOD	-1
27	and	and	O	CC	O	30	NMOD	-1
28	endothelial	endothelial	B-NP	JJ	B-cell_type	30	NMOD	-1
29	progenitor	progenitor	I-NP	NN	I-cell_type	30	NMOD	-1
30	cells	cell	I-NP	NNS	I-cell_type	24	PMOD	-1
31	(	(	O	(	O	33	DEP	-1
32	EPCs	EPC	B-NP	NNS	B-cell_type	33	DEP	-1
33	)	)	O	)	O	30	NMOD	-1
34	and	and	O	CC	O	13	VMOD	-1
35	inhibits	inhibit	B-VP	VBZ	O	13	VMOD	18	inhibits
36	angiogenesis	angiogenesis	B-NP	NN	O	35	OBJ	3	angiogenesis
37	in	in	B-ADVP	FW	O	35	VMOD	-1
38	vitro	vitro	I-ADVP	FW	O	37	AMOD	-1
39	.	.	O	.	O	4	P	-1

1	Moreover	Moreover	B-ADVP	RB	O	10	VMOD	-1
2	,	,	O	,	O	10	P	-1
3	intramuscular	intramuscular	B-NP	JJ	O	4	NMOD	-1
4	p75	p75	I-NP	NN	O	9	NMOD	-1
5	(	(	O	(	O	7	DEP	-1
6	NTR	NTR	B-NP	NN	O	7	DEP	-1
7	)	)	O	)	O	4	NMOD	-1
8	gene	gene	B-NP	NN	O	9	NMOD	-1
9	delivery	delivery	I-NP	NN	O	10	SUB	14	delivery
10	impairs	impair	B-VP	VBZ	O	0	ROOT	18	impairs
11	neovascularization	neovascularization	B-NP	NN	O	15	NMOD	3	neovascularization
12	and	and	I-NP	CC	O	15	NMOD	-1
13	blood	blood	I-NP	NN	O	15	NMOD	-1
14	flow	flow	I-NP	NN	O	15	NMOD	-1
15	recovery	recovery	I-NP	NN	O	10	OBJ	-1
16	in	in	B-PP	IN	O	15	NMOD	-1
17	a	a	B-NP	DT	O	19	NMOD	-1
18	mouse	mouse	I-NP	NN	O	19	NMOD	-1
19	model	model	I-NP	NN	O	16	PMOD	-1
20	of	of	B-PP	IN	O	19	NMOD	-1
21	limb	limb	B-NP	NN	O	22	NMOD	-1
22	ischemia	ischemia	I-NP	NN	O	20	PMOD	-1
23	.	.	O	.	O	10	P	-1

1	These	These	B-NP	DT	O	3	NMOD	-1
2	disturbed	disturbed	I-NP	JJ	O	3	NMOD	-1
3	functions	function	I-NP	NNS	O	4	SUB	0
4	are	be	B-VP	VBP	O	0	ROOT	-1
5	associated	associate	I-VP	VBN	O	4	VC	0
6	with	with	B-PP	IN	O	5	VMOD	-1
7	suppression	suppression	B-NP	NN	O	6	PMOD	0
8	of	of	B-PP	IN	O	7	NMOD	-1
9	signaling	signaling	B-NP	NN	O	10	NMOD	0
10	mechanisms	mechanism	I-NP	NNS	O	8	PMOD	-1
11	implicated	implicate	B-VP	VBN	O	10	NMOD	0
12	in	in	B-PP	IN	O	11	VMOD	-1
13	EC	EC	B-NP	NN	B-cell_type	14	NMOD	-1
14	survival	survival	I-NP	NN	O	16	NMOD	5	survival
15	and	and	I-NP	CC	O	16	NMOD	-1
16	angiogenesis	angiogenesis	I-NP	NN	O	12	PMOD	3	angiogenesis
17	.	.	O	.	O	4	P	-1

1	In	In	B-PP	IN	O	8	VMOD	-1
2	fact	fact	B-NP	NN	O	1	PMOD	-1
3	,	,	O	,	O	8	P	-1
4	p75	p75	B-NP	NN	B-protein	6	NMOD	-1
5	(	(	O	(	I-protein	6	NMOD	-1
6	NTR	NTR	B-NP	NN	I-protein	8	SUB	-1
7	)	)	O	)	I-protein	6	NMOD	-1
8	depresses	depress	B-VP	VBZ	O	0	ROOT	18	depresses
9	the	the	B-NP	DT	O	11	NMOD	-1
10	VEGF-A/Akt/eNOS/NO	VEGF-A/Akt/eNOS/NO	I-NP	NN	O	11	NMOD	-1
11	pathway	pathway	I-NP	NN	O	8	OBJ	0
12	and	and	O	CC	O	8	VMOD	-1
13	additionally	additionally	B-VP	RB	O	8	VMOD	-1
14	reduces	reduce	I-VP	VBZ	O	8	VMOD	18	reduces
15	the	the	B-NP	DT	O	17	NMOD	-1
16	mRNA	mRNA	I-NP	NN	B-RNA	17	NMOD	0
17	levels	level	I-NP	NNS	O	14	OBJ	-1
18	of	of	B-PP	IN	O	17	NMOD	-1
19	ITGB1	ITGB1	B-NP	NN	B-protein	38	NMOD	-1
20	[	[	O	(	O	26	DEP	-1
21	beta	beta	B-NP	NN	B-protein	25	NMOD	-1
22	(	(	O	(	I-protein	25	NMOD	-1
23	1	1	B-NP	CD	I-protein	25	NMOD	-1
24	)	)	O	)	I-protein	25	NMOD	-1
25	integrin	integrin	B-NP	NN	I-protein	26	DEP	-1
26	]	]	O	)	O	19	NMOD	-1
27	,	,	O	,	O	38	P	-1
28	BIRC5	BIRC5	B-NP	NN	B-protein	38	NMOD	-1
29	(	(	O	(	O	31	DEP	-1
30	survivin	survivin	B-NP	NN	O	31	DEP	-1
31	)	)	O	)	O	28	NMOD	-1
32	,	,	O	,	O	38	P	-1
33	PTTG1	PTTG1	B-NP	NN	B-protein	38	NMOD	-1
34	(	(	O	(	O	36	DEP	-1
35	securin	securin	B-NP	NN	O	36	DEP	-1
36	)	)	O	)	O	33	NMOD	-1
37	and	and	O	CC	O	38	NMOD	-1
38	VEZF1	VEZF1	B-NP	NN	B-protein	18	PMOD	-1
39	.	.	O	.	O	8	P	-1

1	Diabetic	Diabetic	B-NP	JJ	O	2	NMOD	-1
2	mice	mouse	I-NP	NNS	O	16	SUB	-1
3	,	,	O	,	O	2	P	-1
4	which	which	B-NP	WDT	O	2	NMOD	-1
5	typically	typically	B-ADVP	RB	O	6	VMOD	-1
6	show	show	B-VP	VBP	O	4	SBAR	-1
7	impaired	impaired	B-NP	JJ	O	10	NMOD	0
8	postischemic	postischemic	I-NP	JJ	O	10	NMOD	-1
9	muscular	muscular	I-NP	JJ	O	10	NMOD	-1
10	neovascularization	neovascularization	I-NP	NN	O	14	NMOD	3	neovascularization
11	and	and	I-NP	CC	O	14	NMOD	-1
12	blood	blood	I-NP	NN	O	14	NMOD	-1
13	perfusion	perfusion	I-NP	NN	O	14	NMOD	0
14	recovery	recovery	I-NP	NN	O	6	OBJ	-1
15	,	,	O	,	O	2	P	-1
16	have	have	B-VP	VBP	O	0	ROOT	-1
17	these	these	B-NP	DT	O	18	NMOD	-1
18	defects	defect	I-NP	NNS	O	16	OBJ	0
19	corrected	correct	B-VP	VBN	O	18	NMOD	-1
20	by	by	B-PP	IN	O	19	VMOD	-1
21	intramuscular	intramuscular	B-NP	JJ	O	23	NMOD	-1
22	gene	gene	I-NP	NN	O	23	NMOD	-1
23	transfer	transfer	I-NP	NN	O	20	PMOD	-1
24	of	of	B-PP	IN	O	23	NMOD	-1
25	a	a	B-NP	DT	O	29	NMOD	-1
26	dominant	dominant	I-NP	JJ	O	29	NMOD	-1
27	negative	negative	I-NP	JJ	O	29	NMOD	0
28	mutant	mutant	I-NP	JJ	O	29	NMOD	-1
29	form	form	I-NP	NN	O	24	PMOD	0
30	of	of	B-PP	IN	O	29	NMOD	-1
31	p75	p75	B-NP	NN	B-protein	30	PMOD	-1
32	(	(	O	(	O	34	DEP	-1
33	NTR	NTR	B-NP	NN	B-protein	34	DEP	-1
34	)	)	O	)	O	31	NMOD	-1
35	.	.	O	.	O	16	P	-1

1	Collectively	Collectively	B-ADVP	RB	O	6	VMOD	-1
2	,	,	O	,	O	6	P	-1
3	our	our	B-NP	PRP$	O	4	NMOD	-1
4	data	datum	I-NP	NNS	O	6	SUB	-1
5	newly	newly	B-ADVP	RB	O	6	VMOD	-1
6	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	-1
7	the	the	B-NP	DT	O	9	NMOD	-1
8	antiangiogenic	antiangiogenic	I-NP	JJ	O	9	NMOD	3	angiogenic
9	action	action	I-NP	NN	O	6	OBJ	18	action
10	of	of	B-PP	IN	O	9	NMOD	-1
11	p75	p75	B-NP	NN	O	18	NMOD	-1
12	(	(	O	(	O	14	DEP	-1
13	NTR	NTR	B-NP	NN	B-protein	14	DEP	-1
14	)	)	O	)	O	11	NMOD	-1
15	and	and	O	CC	O	18	NMOD	-1
16	open	open	B-NP	JJ	O	18	NMOD	-1
17	new	new	I-NP	JJ	O	18	NMOD	-1
18	avenues	avenue	I-NP	NNS	O	10	PMOD	-1
19	for	for	B-PP	IN	O	18	NMOD	-1
20	the	the	B-NP	DT	O	22	NMOD	-1
21	therapeutic	therapeutic	I-NP	JJ	O	22	NMOD	-1
22	use	use	I-NP	NN	O	19	PMOD	0
23	of	of	B-PP	IN	O	22	NMOD	-1
24	p75	p75	B-NP	NN	O	28	NMOD	-1
25	(	(	O	(	O	27	DEP	-1
26	NTR	NTR	B-NP	NN	O	27	DEP	-1
27	)	)	O	)	O	24	NMOD	-1
28	inhibition	inhibition	B-NP	NN	O	23	PMOD	18	inhibition
29	to	to	B-VP	TO	O	30	VMOD	-1
30	combat	combat	I-VP	VB	O	22	NMOD	-1
31	diabetes-induced	diabetes-induced	B-NP	JJ	O	33	NMOD	17	induced
32	microvascular	microvascular	I-NP	JJ	O	33	NMOD	-1
33	liabilities	liability	I-NP	NNS	O	30	OBJ	-1
34	.	.	O	.	O	6	P	-1

